COVID-19 Vaccine J&J

14 Subject Panel

3 samples per subject
Sample 1: < 1 day prior their vaccination
Sample 2: 2 weeks post their vaccination
Sample 3: 2 months post their vaccination
• Some subjects with previous COVID infections
• Serum only
• 1-2 mL samples
• Methodology: DiaSorin LIAISON SARS-CoV-2 S1/S2 IgG

Disclaimer: Individual donor units used in the preparation of this product have been tested and found negative by tests for antibodies to HIV 1 / 2, HCV and non-reactive for HBsAg. Pooled samples were found non-reactive for HIV 1 RNA, HBV DNA and HCV RNA by Nucleic Acid Test. All testing performed with kits approved by the FDA. Each donor has been tested and found negative for syphilis according to FDA guidelines.